| アブストラクト | Despite the growing availability of coronavirus disease 2019 (COVID-19) vaccines in the general population, a significant proportion of individuals demonstrate vaccine hesitancy. We sought to consolidate and update current evidence on cutaneous adverse events from COVID-19 vaccines to aid in the education and counseling of patients concerned about potential cutaneous side effects. We conducted a literature review of PubMed in May 2021 to identify reports of cutaneous events after vaccination with the Pfizer-BioNTech and Moderna vaccines (postauthorization clinical reports pertaining to the Johnson & Johnson and AstraZeneca vaccines were limited). Event reports in the Vaccine Adverse Event Reporting System were reviewed. Localized cutaneous reactions were common after the mRNA vaccines, consistent with clinical trial findings. Reported urticarial and morbilliform eruptions may reflect immediate hypersensitivity but have rarely been associated with anaphylaxis. There are infrequent reports of herpes zoster, dermatologic filler reactions, and immune thrombocytopenia, mainly occurring in high-risk patient groups. Ultimately, the identified cutaneous reactions are largely self-limited and should not discourage vaccination. Existing reports should reassure patients of the overall compelling safety profiles of the mRNA COVID-19 vaccines and benignity of skin reactions after vaccination. |
|---|
| ジャーナル名 | Clinics in dermatology |
|---|
| 投稿日 | 2021/11/24 |
|---|
| 投稿者 | Gronbeck, Christian; Grant-Kels, Jane M |
|---|
| 組織名 | University of Connecticut School of Medicine, Farmington, Connecticut, USA.;Department of Dermatology, University of Connecticut School of Medicine,;Farmington, Connecticut, USA. Electronic address: grant@uchc.edu. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/34809772/ |
|---|
